Clinical trial
Immune Responses to Mycobacterium Tuberculosis
NCT00340990 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00340990 |
|---|---|
| Title | Immune Responses to Mycobacterium Tuberculosis |
| Official title | Pilot Study of CD4+ T Cell Immune Responses to Mycobacterium Tuberculosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Mycobacterium Tuberculosis |
| Enrollment | 111 |
| Start date | Oct 6, 2003 |
| Completion | Nov 27, 2015 |
| First posted | Jun 21, 2006 |
| Last update posted | Dec 5, 2019 |
| Countries | Mali |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: